300 related articles for article (PubMed ID: 28965079)
21. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
[TBL] [Abstract][Full Text] [Related]
22. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
23. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
[TBL] [Abstract][Full Text] [Related]
24. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
[TBL] [Abstract][Full Text] [Related]
25. Study of the pH-sensitive mechanism of tumor-targeting liposomes.
Fan Y; Chen C; Huang Y; Zhang F; Lin G
Colloids Surf B Biointerfaces; 2017 Mar; 151():19-25. PubMed ID: 27940165
[TBL] [Abstract][Full Text] [Related]
26. Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer.
Xu P; Meng Q; Sun H; Yin Q; Yu H; Zhang Z; Cao M; Zhang Y; Li Y
Biomaterials; 2015 Sep; 64():10-20. PubMed ID: 26106797
[TBL] [Abstract][Full Text] [Related]
27. A near-infrared two-photon-sensitive peptide-mediated liposomal delivery system.
Yang Y; Yang Y; Xie X; Cai X; Wang Z; Gong W; Zhang H; Li Y; Mei X
Colloids Surf B Biointerfaces; 2015 Apr; 128():427-438. PubMed ID: 25766920
[TBL] [Abstract][Full Text] [Related]
28. Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution.
Zhang H; Li RY; Lu X; Mou ZZ; Lin GM
J Zhejiang Univ Sci B; 2012 Dec; 13(12):981-9. PubMed ID: 23225853
[TBL] [Abstract][Full Text] [Related]
29. Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma.
Sun L; Zhou DS; Zhang P; Li QH; Liu P
Int J Pharm; 2015 Jan; 478(1):308-317. PubMed ID: 25433201
[TBL] [Abstract][Full Text] [Related]
30. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB
Luo Q; Gong P; Sun M; Kou L; Ganapathy V; Jing Y; He Z; Sun J
J Control Release; 2016 Dec; 243():370-380. PubMed ID: 27810556
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine.
Li S; Wang XP
Int J Nanomedicine; 2017; 12():5797-5804. PubMed ID: 28860749
[TBL] [Abstract][Full Text] [Related]
32. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
[TBL] [Abstract][Full Text] [Related]
33. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.
Xu WW; Liu DY; Cao YC; Wang XY
Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of glycosylated docetaxel-encapsulated liposomes prepared by remote loading under solubility gradient.
Shigehiro T; Zhai W; Vaidyanath A; Masuda J; Mizutani A; Kasai T; Murakami H; Hamada H; Salomon DS; Mikuni K; Seno Y; Mandai T; Seno M
J Microencapsul; 2016; 33(2):172-82. PubMed ID: 26885749
[TBL] [Abstract][Full Text] [Related]
35. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
[TBL] [Abstract][Full Text] [Related]
36. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
[TBL] [Abstract][Full Text] [Related]
37. A Multifunctional Lipid Incorporating Active Targeting and Dual-Control Release Capabilities for Precision Drug Delivery.
Liu C; Ewert KK; Yao W; Wang N; Li Y; Safinya CR; Qiao W
ACS Appl Mater Interfaces; 2020 Jan; 12(1):70-85. PubMed ID: 31774266
[TBL] [Abstract][Full Text] [Related]
38. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
[TBL] [Abstract][Full Text] [Related]
39. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
[TBL] [Abstract][Full Text] [Related]
40. [Preparation and in vitro properties of folate receptor targeting docetaxel-loaded amphiphilic copolymer-modified liposomes].
Li X; Zhang J; Wang DK; Pan WS
Yao Xue Xue Bao; 2012 Sep; 47(9):1219-26. PubMed ID: 23227554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
